.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Population-level evidence from Sweden demonstrated that HPV vaccination was associated with a substantial reduction in invasive cervical cancer, particularly when vaccination occurred at younger ages. The study provides strong real-world evidence that primary prevention can change cancer incidence rather than merely reducing HPV infection or precancerous lesions. For gynecologists, the clinical message is that vaccination and screening are complementary: vaccination does not eliminate the need for screening because it does not cover every oncogenic HPV type and does not treat established infection. The evidence also highlights the importance of coverage and age at vaccination. For India and other settings pursuing cervical-cancer elimination, linking adolescent vaccination with accessible, high-quality screening and follow-up is likely to produce the greatest population impact.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
Population-level evidence from Sweden demonstrated that HPV vaccination was associated with a substantial reduction in invasive cervical cancer, particularly when vaccination occurred at younger ages. The study provides strong real-world evidence that primary prevention can change cancer incidence rather than merely reducing HPV infection or precancerous lesions. For gynecologists, the clinical message is that vaccination and screening are complementary: vaccination does not eliminate the need for screening because it does not cover every oncogenic HPV type and does not treat established infection. The evidence also highlights the importance of coverage and age at vaccination. For India and other settings pursuing cervical-cancer elimination, linking adolescent vaccination with accessible, high-quality screening and follow-up is likely to produce the greatest population impact.
Today
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
Last week
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
